✉️ E-mail: fatmawati@usm.my
🏠 Location:
INFORMM, USM Health Campus, 16150 Kubang Kerian, Kelantan, MALAYSIA
Dr Noor Fatmawati Mokhtar
Dr. Noor Fatmawati Mokhtar is a Senior Lecturer and scientist at the Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM). She earned her PhD in the Mechanism of Cancer from Imperial College London in 2011, following her MSc and BSc degrees from Universiti Kebangsaan Malaysia. Her research primarily focuses on breast cancer metastasis, exploring the roles of voltage-gated sodium channels and epigenetics in tumor aggressiveness. A significant portion of her current work centers on liquid biopsy applications for breast cancer, improving the detection of cancer biomarkers using DNA aptamers, synthetic "chemical antibodies" that serves as highly specific recognition elements in next-generation diagnostic platforms, such as electrochemical biosensors.
(2025-2026)
- Noor et al. (2026) Exploring Neonatal NaV1. 5 Voltage-Gated Sodium Channel as a Therapeutic Target in Cancer, IIUM Medical Journal Malaysia 25 (01)
- Ahmad Sukri et al. (2025) nNav1. 5 mRNA Expression in Triple Negative and Non-Triple Negative Breast Cancer Patients Treated at Hospital Pakar Universiti Sains Malaysia, Asian Pacific Journal of Cancer Prevention 26 (11), 4061-4067
- Mussa et al. (2025) Pharmacological Vitamin C-induced high H2O2 generation mediates apoptotic cell death by caspase 3/7 activation in breast cancer tumor spheroids, Journal of Translational Medicine 23 (1), 31
- Mokhtar et al. (2025) Immunomodulatory effects of bioactive polysaccharides from Pleurotus pulmonarius on LPS-stimulated THP-1 human macrophages, Food Bioscience 63, 105729
- Ching et al. (2025) Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis, Computers in Biology and Medicine 184, 109396
(2026)
- Elucidating the structure and binding mechanism of the two new antibodies (mouse polyclonal pAb#7435 and monoclonal antibody mAb4H8) against nNav1.5 in breast cancer
- Design and evaluation of an aptamer-based quantitative measurement of serum PDL-1 using real-time PCR
(2025/2026):
TFM501 - Molecular Basis of Diseases
TFM522 - Diagnostic Technologies & Biological Markers Discovery
TFM529 - Current Trends in ‘Omics’
TFM531 - Dissertation (Thesis Writing Workshop)
GTB204 - Molecular Biology Techniques
GTB 319/3 – Toxicology